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1. Introduction 
The placenta is a unique organ that supports and drives embryonic development by 
providing an environment for the growth of the fetus, coordinating the different phases of 
embryogenesis, and serving as an interface for maternal-fetal interactions. The placenta is a 
very dynamic organ, where a continuum of phenotypic and morphological changes takes 
place over the course of gestation. Such plasticity is achieved due to a unique epigenetic 
profile that allows for: 1) a rapid growth to timely accommodate the embryo; 2) a marked 
invasiveness that allows implantation and invasion of fetal cells into the maternal 
endometrium; and 3) a specific metabolic activity that spans from growth in a hypoxic 
environment, accession to the maternal blood supply, remodeling of endothelial cell 
functions, to evasion of the immune system, allocation of nutrient resources, disposal of fetal 
waste products, and production of pregnancy-associated hormones (Hu & Cross, 2010). 
Consistently, since the early 1980s, the placenta has been proven to possess an unusual 
epigenetic profile with the lowest level of genomic DNA methylation of all organs across 
different species (Ehrlich et al., 1982; Gama-Sosa et al., 1983). Under the assumption that 
DNA methylation leads to gene silencing, this hypomethylated profile has been attributed 
to the need for the placenta to sustain implantation with promotion of rapid and highly 
coordinated fetoplacental growth and maturation. Somewhat supportive of this hypothesis 
is the discovery that the placenta shares common epigenetic features with tumor tissues 
which display fast growth and invasive morphologic characteristics as well (Guilleret et al., 
2009; Harada, 1978; Perry et al., 2010). 
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1.1 Placenta epigenetics and genomic imprinting 
The intricate network of epigenetic mechanisms that act on the genome modifying its 
expression to determine the phenotype is, as of yet, only poorly understood. DNA 
methylation, histone modification and long non-protein-coding RNAs (lncRNAs) activity 
are the best known of such mechanisms. While studies that explored each of these 
phenomena individually, either in a genome-wide or targeted fashion, struggled to 
determine the full extent of their importance (Lambertini et al., 2011), the integrated 
investigation of their interplay, in the framework of specific molecular pathways linked to 
phenotypical outcomes, is gaining momentum (Q. Li et al., 2011; Qureshi & Mehler, 2011). 
Genomic imprinting is probably the best example of how multiple epigenetic mechanisms 
act on the phenotype. It has in fact been shown that DNA methylation, histone modification 
and lncRNAs, coordinately act in regulating the monoallelic expression of a small subset of 
genes (~1%) in the human genome accordingly to their parent-of-origin. As for all other 
epigenetic mechanisms, imprinting shows tissue-specificity, i.e. genes that are imprinted in 
the placenta are biallelically expressed in other tissues (T.H. Vu et al., 2010). The loss of 
genomic imprinting (LOI) during the early stages of embryogenesis, can lead to placental 
and fetal growth restriction and influence the fetal development into adulthood (Sasaky & 
Ishino, 2006; Tycko, 2006; American Journal of Medical Genetics, 2010). 
Accordingly, experiments on mice showed that induced pluripotent stem cells (iPCs) and 
embryonic stem (ES) cells have indistinguishable global mRNA profiles; however iPCs fail 
to support the development of all-iPCs animals contrary to ES cells. A closer investigation of 
the iPCs and ES mRNA profiles however revealed a reproducible expression difference for 
only 2 transcripts, the lncRNA Meg3 and the small nucleolar RNA Rian, two imprinted 
genes belonging to the Dlk1-Dio3 imprinted domain. Additionally, the expression profiles of 
other imprinted gene sets were found to vary from clone to clone further supporting the 
critical role played by imprinted genes in development (Stadtfeld et al., 2010). 
In another mouse model, bi-maternal embryos obtained from immature primordial oocytes, 
with no established epigenetic imprinting marks, and fully developed oocytes with 
complete sex-specific imprinting signals, were not viable. Placentas of these embryos 
showed both severe growth restriction and abnormal histology. The engineered deletion in 
primordial oocytes of two relatively small regions encompassing the two imprinted gene 
clusters Igf2-H19 and Dlk1-Dio3, alone rescued the phenotype. The placenta was then found 
to develop normally and the associated conceptuses grew normally into adulthood. 
Interestingly, embryos from one normal and one primordial oocyte, alternatively carrying 
only one of the imprinting deletions, resulted in phenotypes affecting placental growth and 
fetal development as well as size and general health status of the progeny (Kawahara et al., 
2009). 
These findings support the fundamental role that imprinted genes play in development 
while contemporaneously highlighting the need, for embryogenesis to proceed regularly, of 
the contribution of genotypes carrying different epigenetic marks (i.e. paternal and 
maternal), as shown in the early 1980s from studies in mice (McGrath & Solter, 1984). This 
condition has been addressed by the “parental conflict theory” which proposes that the 
parent-of-origin specific epigenetic marks of genomic imprinting evolved in animals to 
properly allow for the distribution of maternal resources to each developing embryo (Haig 
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& Graham, 1991; Moore & Haig, 1991). Under this theory a tug-of-war takes place between 
the paternally expressed genes that promote fetal growth to generate a stronger offspring, 
and the maternally expressed genes that have the opposite effect in order to preserve 
maternal energies (McGrath & Solter, 1984). In line with this theory are the findings that 
paternal uniparental disomy (UPD) (paternalization) of the imprinted region of 
chromosome 11, which carries several imprinted gene clusters, results in the Beckwith-
Wiedemann syndrome characterized by a birthweight 50% above normal, accompanied by 
other overgrowth symptoms. On the other hand, maternal UPD (maternalization) of this 
same region leads to Silver-Russell syndrome characterized by perinatal and postnatal 
growth deficiency (Barlow et al., 1991). 
There are also evolutionary findings that support the parental conflict theory. Humans in 
fact show a diminished degree of conservation of the genomic imprinting, particularly for 
maternally expressed genes (Hutter et al., 2010), compared to lower species. This is 
consistent with the observation that singleton pregnancies are much more common in 
humans therefore reducing the need of conservation of maternal energy (Isles, 2009; Monk et 
al., 2006). 
Analysis of the LOI in normal placenta provides additional clues on possible relaxation of 
the imprinting status in humans. Normal placenta samples in fact returned appreciable LOI 
values (>3%) for genes like IGF2, MEST, PEG3, SLC22A18 and TP73 in a pilot study run by 
measuring LOI in a highly quantitative allele-specific real-time PCR (RT-PCR) on 22 
placental RNA samples across 14 imprinted genes (Diplas et al., 2009a; Lambertini et al., 
2008; Lambertini et al., 2009). It has however to be noticed that 3 out of the 5 genes identified 
were paternally expressed (or maternally imprinted) and 2 maternally expressed (or 
paternally imprinted) which speaks more directly for a generalized LOI of imprinted genes 
independently from their parent-of-origin. 
1.2 Genomic imprinting characteristics 
The mechanism by which DNA methylation, histone modification and lncRNAs operate in 
silencing genes accordingly to their parent-of-origin is becoming more and more clear as 
evidence accumulates, even though several points still remain obscure. 
Imprinted genes often reside in clusters spread across all human genome and are expected 
to represent only around 1% of the expressed genes or ~200 genes; of these at present only 
~90 have been experimentally proven. Imprinted genes, both when alone or clustered, are 
invariably regulated by imprinting control regions (ICRs) that determine the silent/active 
status of one of the alleles. ICRs are short DNA sequences with limited shared features that 
show allele-specific methylation at consensus CpG dinucleotides involved in the binding 
with regulatory proteins. Functional CpG dinucleotides invariably appear as 50% 
methylated. Such attributes were discovered in a total of 8 imprinted clusters both in mice 
and humans overlooking the allele-specific expression of a total of nearly 30 genes (Lewis & 
Reik, 2006). ICR-like features have been shown for 5 other regions which have at present 
been linked to a single imprinted gene. The remaining imprinted genes returned mostly 
parent-of-origin specific methylation of the promoter region. ICRs can ultimately be located 
several kilobase pairs (kbp) away from a specific imprinted gene, in non-coding genomic 
areas or in the promoter or gene body of other imprinted genes (Lewis & Reik, 2006). 
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DNA methylation was for several years thought to be the only epigenetic mechanism 
regulating imprinting, recently however experiments on histone modification showed that 
ICRs carry characteristic features of allele-specific methylation of histone H3, acetylation of 
histones H3 and H4 and ubiquitination of histone H2 over specific lysine aminoacidic 
residues. These epigenetic signals have been linked with the stabilization of the 
active/silenced status of each allele (Gieni & Hendzel, 2009; Yang & Kuroda, 2007). 
One question has however always been left unanswered, how can an ICR regulate the 
silencing of one allele of a gene located up to 100 kbp away? The answer to this question 
was tentatively provided by the discovery of lncRNAs. These molecules, which are not 
translated into proteins, are actively transcribed, have lengths often above 1,000 bp and 
carry consensus sequences for the binding of regulatory proteins complexes that can also 
bind ICRs (Bernstein & Allis, 2005). Accordingly, lncRNAs are ideal candidates for 
determining spatial and temporal specificity as transcription regulators by interacting with 
their promoters in a temporally regulated fashion (Mohammad et al., 2009; Yazgan & Krebs, 
2007). From the mechanistic point of view it has been proposed that lncRNAs act by directly 
recruiting chromatin modifying proteins that would participate in the formation of DNA 
loops intended to activate/silence genes and even select between promoters with different 
strength (Lefevre et al., 2008). 
Interestingly only 1.5% of our entire genome encodes mRNAs that are translated into 
proteins while 60-80% of the genome is transcribed into non-protein-coding RNAs (Lee, 
2009). Also while the number of nucleotides encoding protein sequences is relatively 
constant, the number of nucleotides for non-protein-coding sequences increases over a wide 
range of eukaryotic complexity, suggesting that increased complexity itself may be 
explained by an increase in cis-acting regulatory elements driving trans-acting lncRNAs 
(Taft et al., 2007). It has now been proposed that lncRNAs act on silencing specific alleles 
much the same way that the XIST lncRNA acts on silencing one of the X chromosome copies 
in females. In this model, DNA methylation and histone modification marks would act as 
readout signals for lncRNA-protein complexes (Heard et al., 2004). Accordingly, each of the 
identified imprinted clusters expresses at least one lncRNA (Bartolomei, 2009). 
An indirect confirmation of this model comes from the discovery that LOI is a cell-specific 
phenomenon. It has been in fact shown in cell lines that the administration of 5-aza-2’-
deoxycytidine (AZA) induces complete bi-allelic expression in individual clones (Diplas et 
al., 2009b). This finding is thus consistent with a total erasure of the DNA methylation 
readout code therefore leading to a complete binding inhibition of the protein complexes 
that would otherwise drive the allele silencing. 
2. Imprinted genes and development 
Epigenetic imprinting signals are timely reset during the zygote pre-implantation and early 
implantation phases. It has been hypothesized that at this stage the embryo undergoes to a 
basic programming in order to develop according to the environmental conditions it would 
face after birth (Santos & Dean, 2004). 
During pre-implantation the zygote is subjected to a genome-wide wave of de-methylation 
intended to reset this epigenetic signal brought about by the parents. Re-methylation of 
genomic regions takes place accordingly to the new fetal programming. ICRs and ICR-like 
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elements on paternal and maternal alleles are however protected from such changes and 
maintain their parent-of-origin original configuration (Figure 1) (Perera & Herbstman, 2011). 
The hypothesis behind this phenomenon is that, at fertilization, paternal and maternal 
haploid genomes still carry their own epigenetic effector protein complexes that act by 
differentially binding to chromosomal regions to generate sex-specific tridimensional 
organization of the genome. This theory finds a further explanation while looking at the first 
genome-wide de-methylation wave of non-imprinted regions; paternal and maternal 
genomes are in fact stripped at this stage of their DNA methylation signals at a different rate 
with the paternal genotype becoming quickly unmethylated after fertilization while the 
maternal de-methylation proceeds slowly (Reik et al., 2001). Following the resetting of the 
DNA  methylation profiles in a cell type specific fashion, the histone code is reset to further 
 
Fig. 1. Fetal imprinting reprogramming of DNA methylation marks during the early zygote 
developmental phases. F0 sperm and egg carry global (red and blue lines) and imprinting-
specific methylation signals (pink and light blue). After fertilization global methylation is 
reprogrammed at the blastocyst stadium. Imprinting signals are however maintained 
unaltered to generate an embryo with distinct parental contributions. Imprinting 
reprogramming takes place only in the primordial germ cells later in development to 
generate gametes carrying imprinting marks according to the sex of the developing embryo. 
Perturbations of the imprinting profiles at the blastocyst stage can directly affect the embryo 
and also the gametes (F1 and F2 windows) Perturbations happening later affect specifically 
imprinting reprogramming of gametes (F2 window). Somatic cells separately develop from 
the embryo carrying the parental imprinting signals and the newly reprogrammed global 
methylation setting (purple line). They later rearrange their methylation status coherently 
with the adult tissue they will originate (green, orange and brown lines). [Adapted from 
(Perera & Herbstman, 2011)]. 
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stabilize the DNA methylation profile providing the embryo with the articulated network of 
epigenetic signaling carrying the essential parent-of-origin specific setup of the genome 
(Santos & Dean, 2004). 
Later in fetal development a subset of embryonal cells are selected to become primordial 
germ cells (PGCs). In order to guarantee the generation of mature haploid germ cells with 
imprinting marks consistent with the sex of the developing embryo, PGCs undergo to a 
second DNA de/re-methylation programming and histone coding this time specifically 
targeted to imprinted domains (Reik et al., 2001). 
Embryonic DNA methylation and histone modification signals placed in the early zygote 
during these developmental stages together constitute the “code” for lncRNAs to later “read” 
to drive, similarly to the X inactivation process, the gene silencing/activation in a plastic 
and adaptable system during subsequent developmental phases. This same system would 
also determine the tissue specificity of imprinting as shown in the liver where the IGF2–H19 
ICR is still paternally methylated but IGF2 is biallelically expressed (T.H. Vu et al., 2010). 
This highly coordinated system of epigenetic reprogramming creates windows of 
vulnerability during the early phases of the fetal development that extends into the later 
phases, as well as exerting a trans-generational effect when perturbing the correct PGCs 
programming. Such perturbations, depending from the time of occurrence, can in fact 
extend their effect across at least the second generation (Figure 1) and possibly even beyond. 
In this framework, it has been hypothesized that several fetal outcomes can be associated 
with perturbations of the embryo epigenetic reprogramming at different times across the 
windows of susceptibility (Table 1). 
Between these episodes, the prenatal and periconceptional exposure to insufficient maternal 
caloric intake has been found to leave lasting signals on the methylation profile of several 
imprinted genes like INS, IGF2, GNASAS and MEG3 up to 60 years after the triggering 
event. This environmental phenomenon has also been reported to act in a sex-specific way 
with a strict dependence from the exposure timing. Exposures happening late in the 
pregnancy in fact do not leave persistent changes on the methylation profiles (Tobi et al., 
2009). Epidemiologic investigations on exposed subjects concomitantly revealed high rates 
of behavioral disorders and obesity (Lumey, 1998; Roseboom et al., 2006; Susser et al., 1998), 
as confirmed by other investigations in populations with similar exposures (Song et al., 
2009). 
The key role of imprinted genes in placental and fetal development is further shown when 
investigating the other genes with which they network by using informatics tools such as 
Ingenuity Pathway Analysis (IPA) (Ingenuity® Systems – www.ingenuity.com). Imprinted 
gene pathway analyses in fact link these genes to three main areas: 1) cell proliferation, 
assembly, organization, cycling and death; 2) metabolism of lipids and other small 
intracellular signaling molecules that bind proteins and nucleic acids to regulate their 
activity and/or function; and 3) development and function of nervous system, respiratory 
system and other organs. At the same time these genes are listed in the pathways leading to 
developmental, neurological, psychological, skeletal, muscular, genetic, cardiovascular, 
gastrointestinal, hepatic and connective tissue disorders together with cancer in 
agreement with the common epigenetic setting of placental and tumor tissues (Table 2). 
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Event Reference 
1. Phocomelia from prenatal exposure to thalidomide as 
antiemetic in early pregnancy 
(McBride, 1961) 
(Taussig, 1962) 
2. Cerebral palsy, mental retardation, and convulsions from 
prenatal exposure to methyl mercury from contaminated fish  
(Ordonez et al., 1966) 
(Pierce et al., 1972) 
(Bakir et al., 1973) 
(Harada, 1978) 
3. Reduced birth weight and increased incidence of preterm birth 
from prenatal exposure to maternal smoking 
(Underwood et al., 1967) 
(Meyer et al., 1976) 
4. The fetal alcohol syndrome (Lemoine et al., 1968) 
(Ulleland, 1972) 
(Jones & Smith, 1973) 
5. Diminished intelligence and shortening of attention span from 
prenatal exposure to lead  
(Landrigan et al., 1975) 
6. Clear cell adenocarcinoma of the vagina in young women from 
prenatal exposure to the synthetic estrogen diethylstilbestrol 
administered in pregnancy to prevent premature labor 
(Herbst et al., 1981) 
7. Neural tube defect from prenatal exposure to folic acid 
deficiency  
(Molloy et al., 1985) 
8. Low birth weight from prenatal treatment with multiple 
courses of antenatal glucocorticoids 
(Doyle et al., 1989) 
(Thorp et al., 2002) 
9. Behavioral disorders and obesity from prenatal and 
periconceptional exposure to insufficient maternal caloric 
intake 
(Susser et al., 1996) 
(Lumey, 1998) 
(Roseboom et al., 2006) 
10. Reduced head circumference at birth from prenatal exposure to 
organophosphate insecticides 
(Perera et al., 2003) 
(Eskenazi et al., 2004) 
11. Shorter anogenital distance and poorer semen quality in males 
from prenatal exposure to phthalates 
(Swan et al., 2005) 
(Mendiola et al., 2011) 
12. Reduced intelligence from prenatal exposure to 
polychlorinated biphenyls (PCBs)  
(Engel et al., 2007) 
(Wolff et al., 2007) 
13. Reduced intelligence and slowed mentation from prenatal 
exposures to arsenic and manganese in drinking water 
(Khan et al., 2011) 
(Parvez et al., 2011) 
 
Table 1. Neonatal outcomes associated with perturbations of the embryo epigenetic 
reprogramming at different times across the windows of susceptibility. 
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Imprinted Genes Networks 
by Network(2) Functional Areas Associated Disease 
1. CCNE1, CDKN1C, CYR61, 
DLK1, E2F7, GDNF, GRB10, 
H19, HOXD10, IGF2, 
KCNQ1, MAPK12, NGFB, 
NNAT, PCNA, SNURF, 
TP73, WT1 
Cellular Growth 
Proliferation 
Developmental Disorders 
Genetic Disorders 
2. BMPR2, DLGAP2, GRIA1, 
HOXA11, HTR2A, INS, 
MAGI2, NEDD9, PEG3, 
PPP1R9A, SHANK2, 
SNRPN, UBE3A 
Nervous System Dev & Funct Cancer 
Skeletal & Muscular Disorders 
Reproductive System Diseases 
3. CD44, DIRAS3, DLX5, 
EPS15, IL1B, ILK, NDN, 
NLRP2, TFPI2 
Cellular Development 
Cell Cycle 
Cardiovascular Diseases 
4. ATP10A, CCDC86, 
CDKAL1, SGCE, SLC22A3, 
SLC22A18AS  
Small Molecule Biochemistry Gastrointestinal Diseases 
Hepatic System Diseases 
5. CTAG2, CTNND2, 
L3MBTL, MEST, OSBPL5, 
PLAGL1, TCEB3C 
Gene Expression Cancer 
Connective Tissue Disorders 
6. COPG2, CPA4, DHCR24, 
PEG10, ZNF331 
Cell Cycle 
Cellular Development 
Cancer 
7. CTNNA3, KCNQ1OT1, 
PHLDA2 
Organ Development 
Respiratory System Dev & Funct 
Cell Assembly & Organization 
– 
8. GFI1, GNAS, LASS4, LMO1 Lipid Metabolism 
Small Molecule Biochemistry 
Cell Death 
 – 
9. GABRA5, GABRB3, 
GABRG3 
 – Neurological Diseases 
Developmental Disorders 
Psychological Disorders 
10. KCNK9 Cell Death Neurological Diseases 
11. MEG3 Connective Tissue Dev & Funct Behavioral Syndromes 
12. SDHD  – Cancer 
Endocrine System Disorders 
Genetic Disorders 
13. SLC22A18  – Cancer 
Developmental Disorders 
(1): it includes only those genes for which a gene network of reference could be found by imputing all 
imprinted genes experimentally proven. 
(2): networks include biallelically expressed genes not listed here for ease of reading. 
Table 2. Function and Disease Association of IPA networks including imprinted genes(1) 
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It is not surprising that studies in animal models pointed out the importance of imprinted 
genes in the placental and fetal development and phenotype determination (Bressan et al., 
2009). Around 70% of the known imprinted genes are in fact expressed in placenta (Diplas et 
al., 2009a). A first classification of the role that imprinted genes play in development has 
been recently carried out in mice that divided them into genes express exclusively in the 
placenta and genes expressed in both placenta and embryo. The first group is made out of 
genes that regulate the exchange of resources between mother and fetus and are often found 
imprinted only in the placenta. The second group has instead been further subdivided into: 
1) genes that program the metabolism in the early postnatal period to determine growth and 
metabolic phenotype that greatly affect the survival of the offspring; and 2) genes that 
participate in the development of metabolic organs such as the pituitary and pancreas, 
energy processing and storage organs like liver and fat, the hypothalamus and the placenta. 
Imprinted genes of this subgroup have been linked to growth retardation, and brain, bone, 
muscle and liver disorders (Charalambous et al., 2007). 
Characteristic expression profiles of imprinted genes have also been described for the 
placenta and endocrine tissues across species with an associated specific pattern of 
transcription factor binding sites suggestive of the critical role they play in these tissues 
(Steinhoff et al., 2009). 
Additionally it has been shown that the expression of imprinted genes in placenta is tightly 
regulated compared to other genes (Diplas et al., 2009a). Low transcriptional noise has been 
reported for genes that substantially affect the phenotype (Elowitz et al., 2002; Ozbudak et 
al., 2002), lead to lethality (Blake et al., 2003; Fraser et al., 2004), show haploinsufficiency 
(Batada & Hurst, 2007). Given their role and their functionally haploid status, imprinted 
genes have been proposed to belong to this group (Zaitoun et al., 2010). 
3. Imprinted genes dysregulation in fetoplacental development 
Intra-uterine growth restriction (IUGR) and preeclampsia (PE) are by far the most common 
pregnancy outcomes and alone they account for about a third of all preterm births (Little, 
2009). Both IUGR and PE are considered placentation disorders that arise from shallow 
trophoblast invasion with characteristic tissue morphology that leads to uteroplacental 
insufficiency. At the same time a vast body of literature has linked poor placentation with 
numerous chronic and developmental disorders in children (Barker, 1997; Godfrey & 
Barker, 2000; Heijmans et al., 2007) spanning from asthma (Federal Interagency Forum on 
Child and Family Statistics, 2011; US Environmental Protection Agency [US EPA], 2010;) 
and obesity (Centers for Disease Control [CDC], 2011) to neurodevelopmental syndromes 
(Boyle et al., 1994; CDC, 2009), learning disabilities (Pastor & Reuben, 2008), birth defects 
(Paulozzi et al., 1997; L.T. Vu et al., 2008) to even cancer (National Institutes of 
Health/National Cancer Institute [NIH/NCI], 2011). 
Together these diseases all fall in the category of those that would greatly benefit from the 
availability of early diagnostic tools to give healthcare providers an opportunity for 
intervention/prevention to impact the quality of life of the affected subjects and to 
substantially contain the public health expenditure. The development of such epigenetic 
tools into biomarkers for prenatal diagnosis during pregnancy would also extend their 
clinical utility. 
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Analyses of the epigenetic profiles associated with IUGR and PE have revealed a substantial 
correlation with perturbations of the genomic imprinting settings particularly for growth 
restriction. These findings are not surprising in light of the role of imprinted genes in 
regulating placental and fetal development. However links are still lacking that 
unequivocally connect LOI to chronic and developmental syndromes. 
3.1 Pregnancy outcomes 
The first approach developed to investigate the correlation between LOI and IUGR was 
simply based on the analysis of the ICRs methylation status in placentas from 
uncomplicated fetuses and placentas from IUGR fetuses at term. Studies have focused on 
the first identified and extensively characterized IGF2-H19 ICR, also known as IC1 or ICR1, 
because of the experimentally proven opposite effects of IGF2 paternalization and 
maternalization on the embryonic growth. The IGF2-H19 ICR displays typical silencing 
features on the paternal allele including DNA methylation and histone inactivation signals 
absent on the maternal allele, which result in IGF2 expression from the paternal allele and 
H19 from the maternal (Lewis & Reik, 2006). Such studies however failed to provide a clear 
answer, while in fact some investigations found a correlation with loss of methylation at the 
IGF2-H19 ICR and IUGR (Bourque et al., 2010) others showed no differences (Tabano et al., 
2010). 
At the same time it has been shown that IUGR induces contained dysregulation of a small 
subset of imprinted genes (Diplas et al., 2009a). Between them there is PHLDA2, a gene that 
showed a very consisted but contained upregulation in IUGR. This conclusion, while in line 
with previous studies (McMinn et al., 2006), has also been recently proven in studies on 
mice where animals were engineerized to double the Phlda2 dosage. Mice placentas showed 
a dramatic reduction of the junctional zone and perturbations of the glycogen metabolism 
that led to the restriction of the embryonic growth (Tunster et al., 2010). Such findings are 
consistent with the putative role attributed to PHLDA2 as a pleckstrin-homology protein 
involved in intracellular signaling via the binding of lipids within biological membranes. 
There is however no evidence that correlates the expression upregulation of PHLDA2 with 
methylation changes of the PHLDA2 ICR (KvDMR). The same has been shown for other 
dysregulated imprinted genes in IUGR (Diplas et al., 2009a ; Guo et al., 2008). 
Recently a new approach has been developed that determines LOI by highly quantitative 
allele-specific RT-PCR using non-functional single nucleotide polymorphisms (SNPs) at the 
RNA level (Lambertini et al., 2008). By measuring the RNA relative amounts produced by 
each allele, the effect of all known epigenetic signals is taken into account. The analysis of 
these values in normal and IUGR placentas produced two main conclusions: 1) LOI is a 
common phenomenon in human placenta affecting different genes at different extents even 
in morphologically normal tissues; and 2) LOI differentially affects imprinted genes with 
some of them showing widespread appreciable values unrelated to the tissue morphology 
(e.g. IGF2, MEST, PEG3, SLC22A18, TP73), some others that are invariably imprinted with 
again no morphological correlation (e.g. CD44, EPS15, MEG3, PEG10, PHLDA2), and some 
other genes that show consistent LOI values only in IUGR placentas (e.g. DLK1, H19, 
PLAGL1, SNRPN). 
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Quantitative LOI data however showed no correlation with gene expression which, 
challenges the dogma that LOI leads to the reactivation of a silent allele and results in 
increased expression of the affected gene(s). These findings are however in line with new 
studies that instead tie genomic imprinting to the tridimensional chromosome organization 
into physically organized expression networks. In this model lncRNAs, while still tethered 
to the genome during their transcription, would act by recruiting DNA binding proteins 
into complexes that interact with ICRs generating anchoring points for structural proteins 
that would pull genomic regions together into transcriptional hotspots (Court et al., 2011; 
Horike et al., 2005). The disruption of this genomic architecture would lead to uncoordinated 
activation/silencing of imprinted genes (Minard et al., 2009; Zlatanova & Caiafa, 2009). In 
this framework, still to be clarified is the differential role played by the parental origins. 
PE and IUGR share common pathological features even though they develop into distinct 
outcomes with also different clinical progression. It is therefore expected that the two 
outcomes also share common LOI profiles. While logical however this conclusion cannot be 
drawn as of yet. Few data in fact exist on the correlation of genomic imprinting with PE. A 
study on mice in fact proved that dysregulation in pregnant females of the expression of the 
paternally imprinted/maternally expressed Cdkn1c imprinted gene, a potent inhibitor of 
several cyclin/cyclin dependent kinase complexes, leads to PE-like symptoms including 
hypertension, proteinuria, thrombocytopenia, decreased anti-thrombin III activity, and 
increased endothelin levels in late pregnancy. However no data exist that reported LOI of 
CDKN1C in human preeclampsia (Kanayama et al., 2002). More recently instead correlations 
have been found between LOI of H19 and PE in humans (L. Yu et al., 2009). 
Association of perturbations of genomic imprinting with other outcomes has mostly been 
hypothesized about preterm birth given the substantial contribution of the female line (Boyd 
et al., 2009; Little, 2009). 
3.2 Fetal neurodevelopment 
There is a growing recognition of the importance of the intrauterine period of development on 
health and disease throughout life, including mental health. Particularly, research is focused 
on the placenta which serves as the master regulator of the intrauterine environment and plays 
a functional role in shaping fetal development including neurodevelopment. These effects are 
modulated by simultaneous production of many pregnancy related hormones, proteins and 
growth factors thereby fulfilling a critical role in proper intrauterine development. Specifically, 
the placenta has been shown to produce an array of neuropeptide hormones that are 
analogous to those produced by the hypothalamus and pituitary of the brain, including 
GnRH, TRH, GHRH, CRH, and oxytocin (Liu, 2009). Rapid advancements in discovery of 
integrated regulation of neuropeptide homeostasis within and outside the brain as well as 
placenta (Petraglia et al., 1991; Yen, 1991, 1994) has led to the formulation of a new concept that 
the placenta acts as the “third brain” that links the developed (maternal) and developing (fetal) 
brains (Yen, 1994). In turn, alterations to this critical neurodevelopmental function may be a 
major contributor to the pathophysiology of intrauterine insults including illicit drug 
exposures (Lester & Padbury, 2009). 
Although alterations to the development of the hypothalamic–pituitary–adrenal (HPA) axis 
are likely critical mediators of appropriate infant neurodevelopment, it is also clear that 
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additional genes and pathways may be affected by the maternal environment (Fink et al., 
2010), and specifically that alterations to imprinted genes can play a crucial role in 
neurodevelopment. A high proportion of identified imprinted genes are expressed in the 
central nervous system. Maternally expressed imprinted genes are thought to favor the 
development of larger brains (Davies et al., 2005). Children with Beckwith-Wiedemann 
syndrome, which results in part from inappropriate imprinting of specific imprinted gene 
clusters, demonstrate greater than expected proportions of abnormal scores on emotional 
and behavioral scales (Kent et al., 2008). These observation were also confirmed in animal 
models, wherein female mice engineered to be null for the paternally expressed imprinted 
Peg3 gene, exhibit a reduced number of oxytocin-producing neurons in the hypothalamus, 
linking imprinted gene expression to neurodevelopment (L. Li et al., 1999). Recent work has 
also demonstrated that alterations in imprinted gene expression in the placenta are 
associated with infant neurodevelopmental outcome as reflected in prospectively validated 
neurobehavioral measures, and that specifically imprinted genes such as MEG3, HOXA11, 
and HOXD10, which are involved in nervous system, skeletal, and muscular development 
may be mediating these effects (Marsit et al., 2011). Additional research is needed to better 
dissect the roles of individual imprinted genes on infant neurodevelopment and to link 
these alterations to later life mental health and disease. 
3.3 Obesity 
As expected by the role that imprinted genes play in the development of metabolic organs 
that we previously outlined, obesity has been linked to imprinted genes dysregulations both 
in experimental animals and in epidemiologic investigations. 
Knockout mouse models of heterozygous disruption of the imprinted gene Gnas, encoding 
the heterotrimeric G protein alpha-subunit that coordinates the stimulation of the adenylyl 
cyclase, returned obese mice following the inactivation of the maternal allele and slim mice 
when the paternal allele was disrupted. Interestingly homozygous knockout mice were not 
viable (L. Yu et al., 2009; S. Yu et al., 2000). These data were later confirmed in humans 
(Plagge et al., 2008) and support the link between obesity and imprinted genes dysregulation 
that was already describe in the mid 1970s while analyzing a population of young men 
conceived during a famine episode in the Netherlands (Ravelli et al., 1976). This same 
population was later shown to carry an altered DNA methylation profile in the IGF2-H19 
region (Heijmans et al., 2007; Tobi et al., 2009). In agreement with these are the numerous 
studies that linked metabolic alteration and overgrowth with disturbances of the imprinting 
profile (Barlow et al., 1991; Bressan et al., 2009). 
4. The proposed role of genomic imprinting in fetoplacental development 
Placental and fetal developments are accomplished across the relative short period of time 
of the pregnancy, therefore requiring a highly coordinated regulation of the genome to 
support the different phases of this process. The correct development can thus be achieved 
only by the activation of plastic and adaptable systems that are able to timely rearrange the 
functioning genes based on changes in the environment and the developmental program. 
Genomic imprinting is emerging as the best candidate for such role. It has been in fact 
shown that imprinted genes have a different level of imprinting in placenta during 
pregnancy. First trimester placentas return widespread higher LOI values compared to term 
placentas (Pozharny et al., 2010; L. Yu et al., 2009). 
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Specifically genes like CD44 and EPS15 show a drastic LOI reduction from the first to third 
trimester of pregnancy (Pozharny et al., 2010). These data are particular interesting if we 
consider that CD44 is translated into a protein that participates in cell-cell interactions, 
adhesion and migration, and it has been tied to tumor metastasis promotion. Given the very 
fast growing and invasive nature of the placenta in the first trimester, CD44 would therefore 
be critical for supporting this phase. EPS15 instead encodes a peptide involved in receptor-
mediated endocytosis of the epidermal growth factor; this gene has been linked to acute 
myelogenous leukemia. EPS15 would thus represent a key player in the process of 
establishing the appropriate maternal blood supply in the placenta to assist the fetal growth. 
The analysis of these findings supports the hypothesis that the “gain of imprinting” of 
imprinted genes during the different stages of fetoplacental development would add an 
additional layer of control on their activity. It has been proposed that this phenomenon is 
driven by the timely activation of effectors lncRNAs (Kacem & Feil, 2009), of which 
imprinted genes are substantially provided, that act by silencing one gene copy accordingly 
to the parent-of-origin, similarly to other known lncRNAs as XIST and HOTAIR (Gupta et 
al., 2010; Lee, 2009). It is however not known why this process silence one specific allele and 
take place without altering the resulting expression profile of these genes. 
Similar findings were recently reported in cultured human PGCs. In this model imprinting 
of some genes appeared very early after fertilization, while other genes showed complete 
imprinting only starting at 5 to 11 weeks after fertilization (Crane et al., 2009), again 
demonstrating the plasticity of this epigenetically driven phenomenon. 
The common opinion that is gaining support is that genomic imprinting bimodally acts by 
adding layers of controls on the genome to regulate its activity according to environmental 
signals. This theory is supported by experiments on animals that showed that both in early 
developmental phases and in adult life, environmental signals trigger the activation of 
pathways that modify the complex epigenetic signaling controlling gene expression (Reik et 
al., 2001; Santos & Dean, 2004). These studies provide critical information on the effect of the 
gene-environment interplay on the physiology of organisms (Zhang & Meaney, 2010). An 
example of this condition in humans is represented by the data indicating that common 
environmental changes (such as dietary changes) may result in statistically significant 
epigenetic variations on DNA methylation of imprinted loci (Tobi et al., 2009). 
In the bimodal imprinting model, DNA methylation and histone modification signals are 
placed on the genome very early in development when the zygote reprogramming takes 
place. They represent the first event leading to imprinting. Perturbations of this phase 
would most probably lead to the more severe effects on growth and development because it 
deprives the genome of the critical anchors for the imprinting machinery to recognize the 
areas to act upon. This hypothesis is confirmed, both at the genetic and epigenetic level, by 
studies on severe neurodevelopmental syndromes such as Prader-Willi and Angelman 
which have been correlated to inappropriate imprinting at the chromosome location 15q11 
(Driscoll et al., 1992; Hamabe et al., 1991; Williams et al., 1990). Additionally, immediately 
after implantation, PGCs are selected to be programmed accordingly to the sex of the 
developing embryo; at this stage the improper placement of epigenetic signals acquires its 
transgenerational meaning. PGCs programming in fact is supposed to work by applying the 
epigenetic “code” of the allele consistent with the fetal sex, to the other allele. If “code” 
perturbations have been generated during the zygote reprogramming, they are therefore 
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passed into PGCs. Accordingly, it has recently been shown that, during pregnancy, maternal 
exposure to phthalates, a family of chemicals with known potential for the perturbation of 
the epigenetic profile, specifically target the correct male fetal development. Male babies 
from exposed mothers show reduced anogenital distance and, later in life, low sperm count 
(Mendiola et al., 2011). 
lncRNAs represent instead the second level of imprinting. lncRNAs act by assembling 
protein complexes that have several functions spanning from the regulation of the activity of 
enhancers (Mohammad et al., 2009), assembly of transcription complexes (Royo & Cavaille, 
2008) to generation of transcriptional hotspots (Yang & Kuroda, 2007). The timely 
expression of these molecules is critical for the proper activation/silencing of gene sets. 
Later in life, lncRNAs would also restore biallelic expression of genes accordingly to the 
tissue, possibly also leading to a loss of methylation of unused and unprotected ICRs (Gieni 
& Hendzel, 2009). Perturbations of this second regulation layer would give way to other, 
possibly less severe and reversible, syndromes. 
LOI has been implicated in the etiology of growth restriction syndromes and both conditions 
have been independently associated with chronic and developmental disorders that greatly 
impact the health of children – Barker Hypothesis (Barker, 1997) – with the potential of 
limiting their quality of life into adulthood, often resulting in reduced life expectancy. Chronic 
disorders in young adults also entail a great deal of expenditure due to the necessary life-long 
treatments (Landrigan & Goldman, 2011; Trasande, 2011; Trasande & Liu, 2011). The study of 
perturbations in genomic imprinting can shed light into the mechanisms leading to these 
disorders. The complete characterization of LOI also bears the promise of developing its 
highly quantitative measurement into new groundbreaking biomarkers that could have a 
major impact on public health by allowing early diagnosis of several pathologies correlated 
with placentation disorders, as well as on biomedical, behavioral and clinical research 
(Maccani & Marsit, 2009). The completion of the analysis of the imprinting in placenta at 
different developmental stages is critical to achieve this goal (Pozharny et al., 2010). 
After this, the next logical step is to develop a method that allows monitoring the imprinting 
status during pregnancy. New technological tools are now available to carry out quantitative 
RT-PCR experiments on single DNA/RNA molecules therefore opening the way to the 
challenge of measuring LOI in cells isolated from the amniocentesis fluid or from chorionic 
villi sampling (CVS). These advancements could be an opportunity to predict those 
pregnancies at risk of developing obstertrical disorders such as PE or IUGR and even fetuses at 
risk for future diagnosis of developmental diseases back to the first trimester of pregnancy. 
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